Invention Grant
- Patent Title: Anhydrous lenalidomide form-I
-
Application No.: US14794275Application Date: 2015-07-08
-
Publication No.: US10040778B2Publication Date: 2018-08-07
- Inventor: Durga Prasad Konakanchi , Buchappa Gongalla , Kotayya Babu Sikha , Chandrasekar Kandaswamy , Kali Satya Bhujanga Rao Adibhatla , Venkaiah Chowdary Nannapaneni
- Applicant: Natco Pharma Limited
- Applicant Address: IN
- Assignee: NATCO PHARMA LIMITED
- Current Assignee: NATCO PHARMA LIMITED
- Current Assignee Address: IN
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo PC
- Main IPC: C07D401/04
- IPC: C07D401/04
Abstract:
Anhydrous polymorphic form-I of anti cancer drug, Lenalidomide whose chemical name is 3-(4-amino-1-oxo-1,3-dihydro-isoindole-2-yl)-piperidine-2,6-dione, is disclosed. Alternate methods for making anhydrous polymorphic form-I of Lenalidomide are also disclosed.
Public/Granted literature
- US20150353525A1 ANHYDROUS LENALIDOMIDE FORM-I Public/Granted day:2015-12-10
Information query
